Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 2/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27781433 | 0.84 | TSHR (0.43) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL11428709 | 0.83 | TDP1 (0.47) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL4070149 | 0.83 | TSHR (0.39) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL8493145 | 0.82 | ALDH1A1 (0.32) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL27771526 | 0.81 | THRB (0.42) | ALDH1A1TSHR | |
| SCHEMBL7709890 | 0.80 | ALDH1A1 (0.40) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL9810935 | 0.80 | TSHR (0.40) | ALDH1A1TSHRLMNATDP1CHRM2 | |
| SCHEMBL202380 | 0.80 | ALDH1A1 (0.40) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL2802408 | 0.80 | ALDH1A1 (0.42) | ALDH1A1TSHRPRKCA | |
| SCHEMBL4400024 | 0.79 | ALDH1A1 (0.32) | ALDH1A1TSHRLMNAHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207130-B1 | REACTING A CARBOXYLATO-ALUMOXANE (MONOCARBOXYLIC ACID LIGANDS) WITH A METAL ACETOACETONATE SOLUBILIZED OR DISPERSED IN A SOLVENT; ISOLATING AND CALCINING; GARNETS, SPINELS; HEAT AND CHEMICAL RESISTANCE | RICE UNIVERSITY | 2001-03-27 | — | — | US | claimed |
| US-9067845-B2 | Process for hydrochlorination of multihydroxylated aliphatic hydrocarbons | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-30 | — | — | US | disclosed |
| EP-2047061-B1 | A COMPOSITION AND METHOD FOR MAKING A PROPPANT | OXANE MATERIALS INC (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8603578-B2 | Composition and method for making a proppant | OXANE MATERIALS, INC. (US) | 2013-12-10 | — | — | US | disclosed |
| CN-103262305-A | Surface protective agent composition for battery electrode or separator, battery electrode or separator protected by same, and battery having same | KYORITSU CHEMICAL CO LTD | 2013-08-21 | — | — | CN | disclosed |
| EP-2576489-A1 | PROCESS FOR HYDROCHLORINATION OF MULTIHYDROXYLATED ALIPHATIC HYDROCARBONS | Dow Global Technologies LLC (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20130066091-A1 | PROCESS FOR HYDROCHLORINATION OF MULTIHYDROXYLATED ALIPHATIC HYDROCARBONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-03-14 | — | — | US | disclosed |
| US-20130022816-A1 | Composition And Method For Making A Proppant | OXANE MATERIALS, INC. (US) | 2013-01-24 | — | — | US | disclosed |
| US-8298667-B2 | Composition and method for making a proppant | Oxane Materials (US) | 2012-10-30 | — | — | US | disclosed |
| US-8075997-B2 | Composition and method for making a proppant | OXANE MATERIALS, INC. (US) | 2011-12-13 | — | — | US | disclosed |
| EP-2047061-A2 | A COMPOSITION AND METHOD FOR MAKING A PROPPANT | Oxane Materials, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| US-7491444-B2 | Composition and method for making a proppant | OXANE MATERIALS, INC. (US) | 2009-02-17 | — | — | US | disclosed |
| WO-2009012455-A1 | PROPPANTS WITH CARBIDE AND/OR NITRIDE PHASES | OXANE MATERIALS, INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| WO-2008018966-A2 | A COMPOSITION AND METHOD FOR MAKING A PROPPANT | OXANE MATERIALS, INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| US-20070202318-A1 | Composition and method for making a proppant | HALLIBURTON ENERGY SERVICES, INC. | 2007-08-30 | — | — | US | disclosed |
| US-20070166541-A1 | Composition and method for making a proppant | HALLIBURTON ENERGY SERVICES, INC. | 2007-07-19 | — | — | US | disclosed |
| US-6936306-B1 | Chemical control over ceramic porosity using carboxylate-alumoxanes | WILLIAM MARSH RICE UNIVERSITY (US) | 2005-08-30 | — | — | US | disclosed |
| EP-1319639-A2 | Chemical control over ceramic porosity using carboxylate-alumoxanes | William Marsh Rice University (US) | 2003-06-18 | — | — | EP | disclosed |
| EP-1070029-A1 | CHEMICAL CONTROL OVER CERAMIC POROSITY USING CARBOXYLATE-ALUMOXANES | William Marsh Rice University (US) | 2001-01-24 | — | — | EP | disclosed |
| WO-1999050203-A1 | CHEMICAL CONTROL OVER CERAMIC POROSITY USING CARBOXYLATE-ALUMOXANES | WM MARSH RICE UNIVERSITY (US) | 1999-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066091-A1 | PROCESS FOR HYDROCHLORINATION OF MULTIHYDROXYLATED ALIPHATIC HYDROCARBONS | HDHD5, HRH3, HRH1 | ALDH1A1 1034/4885TSHR 3287/4885LMNA 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.